Back
Pacific Biosciences of California Vs. ResMed Industry Stock Comparison
Buy
55
PACB
Pacific Biosciences of California
Last Price:
1.68
Seasonality Move:
2.7%
Buy
54
RMD
ResMed
Last Price:
212.90
Seasonality Move:
6.4%
Buy
55
Pacific Biosciences of California (PACB)
is a Buy
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.86. The Score for PACB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PACB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
ResMed (RMD)
is a Buy
Is ResMed a Buy, Sell or Hold?
- The current ResMed [RMD] share price is $216.16. The Score for RMD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- RMD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.
RMD Stock Price Chart
PACB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 37.7 | Sell |
| Chaikin Money Flow: | -6374222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.36 - 3.06) | Sell |
| Bollinger Bands (100): | (2.77 - 7.97) | Sell |
RMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.21 | Buy |
| Relative Strength Index (14 RSI): | 68.59 | Buy |
| Chaikin Money Flow: | -338516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (179.63 - 210.41) | Buy |
| Bollinger Bands (100): | (172.7 - 197.2) | Buy |
PACB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.73 | Buy |
| 20-day SMA: | 1.91 | Sell |
| 50-day SMA: | 3.2 | Sell |
| 200-day SMA: | 7.34 | Sell |
| 8-day EMA: | 1.79 | Buy |
| 20-day EMA: | 2.05 | Sell |
| 50-day EMA: | 3.18 | Sell |
| 200-day EMA: | 6.52 | Sell |
RMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 216.56 | Sell |
| 20-day SMA: | 196.68 | Buy |
| 50-day SMA: | 191.56 | Buy |
| 200-day SMA: | 172.22 | Buy |
| 8-day EMA: | 212.04 | Buy |
| 20-day EMA: | 202.29 | Buy |
| 50-day EMA: | 193.42 | Buy |
| 200-day EMA: | 184.74 | Buy |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.16 per share, and an increase next year of $0.19 per share.
ResMed Earnings Growth & RMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.07 per share, an increase this year of $1.20 per share, and an increase next year of $0.90 per share.
Pacific Biosciences of California Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ResMed Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||